February 5, 2016
Recommended Topic Related To:

Dritho-Scalp

"The US Food and Drug Administration (FDA) has approved a foam containing calcipotriene and betamethasone dipropionate (Enstilar, Leo Pharma Inc) for topical treatment of plaque psoriasis in adults 18 years of age and older, according to a "...

A A A

Dritho-Scalp




Overdosage
Contraindications

OVERDOSE

No information provided.

CONTRAINDICATIONS

In patients with acute psoriatic eruptions or a history of hypersensitivity to any of the ingredients.

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 5/26/2011

Overdosage
Contraindications

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.